Rhonda Farnum sold $114k of TBPH
SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc.. 10,000 shares at an average of $11.39, traded Jul 14, 2025, filed Jul 16, 2025.
Score components
- +15RoleOfficer
- +10Trade size$114k at market
- 0Share of holdings soldSold 3.0% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-019869, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 14, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -682 | $11.39 | $7,770 | 336,236 | Jul 16, 2025 |
| Jul 14, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -5,318 | $11.39 | $61k | 330,918 | Jul 16, 2025 |
| Jul 14, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -4,000 | $11.39 | $46k | 326,918 | Jul 16, 2025 |
Related signals
Other insiders at Theravance Biopharma, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | $227k 13,314 shares | -6% | |
| 9Weak | Theravance Biopharma, Inc. | Eran Broshy director | $590k 29,501 shares | -40% | |
| 25Weak | Theravance Biopharma, Inc. | Eran Broshy director | $1.1M 59,000 shares | -65% | |
| 8Weak | Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | $264k 24,000 shares | -7% | |
| 1Weak | Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | $36k 4,000 shares | -1% | |
| 1Weak | Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | $36k 4,000 shares | -1% | |
| 21Weak | TBPHsell Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | $36k 4,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.